Communiqués Boston Scientific Corporation

Actions

BSX

US1011371077

Equipement et technologie médicale avancés

Marché Fermé - NYSE 22:00:02 16/09/2026			Varia. 5j.	Varia. 1 janv.
43,91 ^USD	+0,09%		-2,34%	-53,95%

14/09	Boston Scientific Corporation : Bernstein persiste à l'achat	ZM
12/09	Boston Scientific Corporation rappelle les systèmes de monitorage cardiaque insérables LUX-Dx, LUX-Dx II, LUX-Dx II+, SERVER SW LAT CLARITY DS EU, modèle numéro 7246	CI

Communiqués

26/08	Boston Scientific : Update on recent cybersecurity incident	PU
13/08	CAFC Reverses Jury Decision In Board Of Regents Of The University Of Texas System v. Boston Scientific Corp.	AQ
10/08	A $50 Million Patent Verdict Vanished On Appeal. Here Is What Founders Should Learn From It.	AQ
10/08	Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results	PR
30/07	Penumbra, Inc. Reports Second Quarter 2026 Financial Results	PR
29/07	Boston Scientific: Q2 Earnings Snapshot	AQ
29/07	Boston Scientific announces results for second quarter 2026	PR
02/07	Boston Scientific : Four things to know about our acquisition of Valencia Technologies	PU
22/06	Class Action Launched Over Alleged Defects In Pacemakers	AQ
19/05	FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints	PR
18/05	Boston Scientific enters into $2 billion accelerated share repurchase agreement	PR
18/05	Boston Scientific announces strategic investment in MiRus LLC	PR
06/05	Penumbra, Inc. Reports First Quarter 2026 Financial Results	PR
04/05	Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results	PR
03/05	BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026	NE
02/05	BSX 72 HOUR DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026	NE
01/05	BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026	PR
30/04	BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented U.S. Electrophysiology Market Growth and Downplayed Competitive Pressures: SueWallSt	PR
29/04	BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026	NE
29/04	BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Hid Weakening U.S. Electrophysiology Sales Trends: Levi & Korsinsky	PR
28/04	BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026	NE
28/04	Lost Money on Boston Scientific Corporation (BSX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm	PR
26/04	Data at Heart Rhythm 2026 highlight key Boston Scientific therapies	PR
25/04	BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026	NE
23/04	BSX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026	NE